CLIA HbA1c Control (UDI 06974521001676)
Manufactured by Shenzhen Superbio Technology Co.,Ltd.
Device Regulatory Overview
The CLIA HbA1c Control (Model/Catalog Number: MQC046) is a medical device manufactured by Shenzhen Superbio Technology Co.,Ltd.. This product is indexed under FDA Product Code / Category Classification W0102152003 within international Unique Device Identification (UDI) compliance databases.
Technical Specifications
- Model Number
- MQC046
- Product Code / EMDN
- W0102152003
- Device Name
- CLIA HbA1c Control
- Database Sync Date
- 2026-08-09 16:46:55
Full Regulatory Attributes
🔒 Token Gated
{
"review_panel": "AN",
"gudid_di_status": "Published",
"sterilization_methods": ["EO", "Gamma"],
"rx_only": true
}
Unlock Compliance Data & Serialization Specs
Access raw JSON payloads, UDI-DI packaging hierarchies, and Notified Body IDs.
Get API Token Access ($49/mo)Frequently Asked Questions
Who is the primary manufacturer of CLIA HbA1c Control?
The registered manufacturer of record for CLIA HbA1c Control is Shenzhen Superbio Technology Co.,Ltd..
What is the Primary UDI-DI identifier for CLIA HbA1c Control?
The Primary UDI-DI identifier registered in FDA GUDID and EUDAMED records is 06974521001676.
What classification code is assigned to this device?
This device is registered under product classification code W0102152003.
Similar Classification Devices (W0102152003)
Other Devices by Shenzhen Superbio Technology Co.,Ltd.
Programmatic Export
Export this master device record as standardized JSON or CSV for compliance audits.
JSON API Endpoint